Statistics from Altmetric.com
Due to decreased vascular compliance, hypertension in older patients is commonly limited to systolic blood pressure; pulse pressures are wider than for younger patients. Decades ago, physicians commonly withheld treatment for older patients with isolated systolic hypertension due to a belief that this was a ‘normal’ or acceptable consequence of ageing that carried no excess morbidity. Since the early 1990's, multiple large-scale treatment trials disproved this hypothesis. These included the Syst-Eur and Syst-China trials of nitrendipine, and the MRC(Medical Research Council) trial of hydrochlorothiazide plus amiloride.
One of the largest and most influential trials was the Systolic Hypertension in the Elderly Program (SHEP) study.1 In this trial, eligible patients were above the age of 60 (mean 71.6 years), had no pre-existing …
Competing interests None.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.